Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0100
+0.0005 (5.26%)
Aug 27, 2025, 3:59 PM EDT
Evofem Biosciences Employees
Evofem Biosciences had 32 employees as of December 31, 2024. The number of employees decreased by 6 or -15.79% compared to the previous year.
Employees
32
Change (1Y)
-6
Growth (1Y)
-15.79%
Revenue / Employee
$539,688
Profits / Employee
-$195,156
Market Cap
1.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32 | -6 | -15.79% |
| Dec 31, 2023 | 38 | 1 | 2.70% |
| Dec 31, 2022 | 37 | -82 | -68.91% |
| Dec 31, 2021 | 119 | -28 | -19.05% |
| Dec 31, 2020 | 147 | 94 | 177.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| Elite Pharmaceuticals | 68 |
| American Oncology Network | 1,914 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
Evofem Biosciences News
- 6 days ago - Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law - PRNewsWire
- 8 days ago - FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis - PRNewsWire
- 13 days ago - Evofem Biosciences GAAP EPS of -$0.02, revenue of $4.8M - Seeking Alpha
- 13 days ago - Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update - PRNewsWire
- 22 days ago - Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference - PRNewsWire
- 2 months ago - Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store - PRNewsWire
- 2 months ago - Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors - Business Wire
- 3 months ago - Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1 - PRNewsWire